104 related articles for article (PubMed ID: 11323365)
1. Can inflammatory pain prevent the development of acute tolerance to alfentanil?
Kissin I; Bright CA; Bradley EL
Anesth Analg; 2001 May; 92(5):1296-300. PubMed ID: 11323365
[TBL] [Abstract][Full Text] [Related]
2. Acute tolerance to continuously infused alfentanil: the role of cholecystokinin and N-methyl-D-aspartate-nitric oxide systems.
Kissin I; Bright CA; Bradley EL
Anesth Analg; 2000 Jul; 91(1):110-6. PubMed ID: 10866896
[TBL] [Abstract][Full Text] [Related]
3. The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations?
Kissin I; Bright CA; Bradley EL
Anesth Analg; 2000 Dec; 91(6):1483-8. PubMed ID: 11094005
[TBL] [Abstract][Full Text] [Related]
4. Magnitude of acute tolerance to opioids is not related to their potency.
Kissin I; Brown PT; Bradley EL
Anesthesiology; 1991 Nov; 75(5):813-6. PubMed ID: 1659255
[TBL] [Abstract][Full Text] [Related]
5. Time course characteristics of acute tolerance development to continuously infused alfentanil in rats.
Kissin I; Lee SS; Arthur GR; Bradley EL
Anesth Analg; 1996 Sep; 83(3):600-5. PubMed ID: 8780289
[TBL] [Abstract][Full Text] [Related]
6. Does midazolam inhibit the development of acute tolerance to the analgesic effect of alfentanil?
Kissin I; Brown PT; Bradley EL
Life Sci; 1993; 52(8):PL55-60. PubMed ID: 8445997
[TBL] [Abstract][Full Text] [Related]
7. Lack of rapid development of opioid tolerance during alfentanil and remifentanil infusions for postoperative pain.
Schraag S; Checketts MR; Kenny GN
Anesth Analg; 1999 Sep; 89(3):753-7. PubMed ID: 10475319
[TBL] [Abstract][Full Text] [Related]
8. Rapid development of tolerance to analgesia during remifentanil infusion in humans.
Vinik HR; Kissin I
Anesth Analg; 1998 Jun; 86(6):1307-11. PubMed ID: 9620525
[TBL] [Abstract][Full Text] [Related]
9. Effect of midazolam on development of acute tolerance to alfentanil: the role of pharmacokinetic interactions.
Kissin I; Lee SS; Arthur GR; Bradley EL
Anesth Analg; 1997 Jul; 85(1):182-7. PubMed ID: 9212144
[TBL] [Abstract][Full Text] [Related]
10. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
Edwards SR; Mather LE; Smith MT
Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
[TBL] [Abstract][Full Text] [Related]
11. Continuous intrathecal administration of shortlasting mu opioids remifentanil and alfentanil in the rat.
Buerkle H; Yaksh TL
Anesthesiology; 1996 Apr; 84(4):926-35. PubMed ID: 8638848
[TBL] [Abstract][Full Text] [Related]
12. Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain.
Rezende RM; França DS; Menezes GB; dos Reis WG; Bakhle YS; Francischi JN
Br J Pharmacol; 2008 Feb; 153(4):760-8. PubMed ID: 18157167
[TBL] [Abstract][Full Text] [Related]
13. Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.
Beaudry H; Gendron L; Morón JA
Eur J Neurosci; 2015 Apr; 41(7):901--7. PubMed ID: 25639561
[TBL] [Abstract][Full Text] [Related]
14. Analgesic and cognitive effects of intravenous ketamine-alfentanil combinations versus either drug alone after intradermal capsaicin in normal subjects.
Sethna NF; Liu M; Gracely R; Bennett GJ; Max MB
Anesth Analg; 1998 Jun; 86(6):1250-6. PubMed ID: 9620514
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat.
Mandema JW; Wada DR
J Pharmacol Exp Ther; 1995 Dec; 275(3):1185-94. PubMed ID: 8531080
[TBL] [Abstract][Full Text] [Related]
16. Patient-controlled alfentanil. Target-controlled infusion for postoperative analgesia.
Irwin MG; Jones RD; Visram AR; Kenny GN
Anaesthesia; 1996 May; 51(5):427-30. PubMed ID: 8694152
[TBL] [Abstract][Full Text] [Related]
17. Endogenous opioids released during non-nociceptive environmental stress induce latent pain sensitization Via a NMDA-dependent process.
Le Roy C; Laboureyras E; Gavello-Baudy S; Chateauraynaud J; Laulin JP; Simonnet G
J Pain; 2011 Oct; 12(10):1069-79. PubMed ID: 21723199
[TBL] [Abstract][Full Text] [Related]
18. The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids.
Rezende RM; Dos Reis WG; Duarte ID; Lima PP; Bakhle YS; de Francischi JN
Pain; 2009 Mar; 142(1-2):94-100. PubMed ID: 19186002
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of monomodal analgesia with IV alfentanil during burn dressing changes at bedside (in spontaneously breathing non-intubated patients).
Fontaine M; Latarjet J; Payre J; Poupelin JC; Ravat F
Burns; 2017 Mar; 43(2):337-342. PubMed ID: 27613475
[TBL] [Abstract][Full Text] [Related]
20. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
Freye E; Latasch L
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
